WallStreetZenWallStreetZen

NASDAQ: JAGX
Jaguar Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for JAGX

Based on 1 analyst offering 12 month price targets for Jaguar Health Inc

Min Forecast
$60.00+1,619.2%
Avg Forecast
$60.00+1,619.2%
Max Forecast
$60.00+1,619.2%

Should I buy or sell JAGX stock?

Based on 1 analyst offering ratings for Jaguar Health Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although JAGX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates JAGX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their JAGX stock forecasts and price targets.

JAGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-19

1 of 1

Forecast return on equity

Is JAGX forecast to generate an efficient return?

Company
-324.59%
Industry
29.19%
Market
56.78%
JAGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JAGX forecast to generate an efficient return on assets?

Company
-11.24%
Industry
10.83%
JAGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JAGX earnings per share forecast

What is JAGX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$23.81
Avg 2 year Forecast
-$5.68

JAGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JAGX$3.49$60.00+1,619.20%Strong Buy
NBY$0.60N/AN/A
SPRC$0.32N/AN/A
SONN$1.15$20.00+1,639.13%Strong Buy
THAR$1.29N/AN/A
View Top Biotech Stocks

Jaguar Health Stock Forecast FAQ

Is Jaguar Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: JAGX) stock is to Strong Buy JAGX stock.

Out of 1 analyst, 1 (100%) are recommending JAGX as a Strong Buy, 0 (0%) are recommending JAGX as a Buy, 0 (0%) are recommending JAGX as a Hold, 0 (0%) are recommending JAGX as a Sell, and 0 (0%) are recommending JAGX as a Strong Sell.

If you're new to stock investing, here's how to buy Jaguar Health stock.

What is JAGX's earnings growth forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.2%.

Jaguar Health's earnings in 2025 is -$39,730,000.On average, 1 Wall Street analyst forecast JAGX's earnings for 2025 to be -$24,246,866, with the lowest JAGX earnings forecast at -$24,246,866, and the highest JAGX earnings forecast at -$24,246,866.

In 2026, JAGX is forecast to generate -$5,784,217 in earnings, with the lowest earnings forecast at -$5,784,217 and the highest earnings forecast at -$5,784,217.

What is JAGX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: JAGX) forecast ROE is -324.59%, which is considered weak.

What is JAGX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year JAGX price target, the average JAGX price target is $60.00, with the highest JAGX stock price forecast at $60.00 and the lowest JAGX stock price forecast at $60.00.

The Wall Street analyst predicted that Jaguar Health's share price could reach $60.00 by May 19, 2026. The average Jaguar Health stock price prediction forecasts a potential upside of 1,619.2% from the current JAGX share price of $3.49.

What is JAGX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's current Earnings Per Share (EPS) is -$152.39. On average, analysts forecast that JAGX's EPS will be -$23.81 for 2025, with the lowest EPS forecast at -$23.81, and the highest EPS forecast at -$23.81. In 2026, JAGX's EPS is forecast to hit -$5.68 (min: -$5.68, max: -$5.68).

What is JAGX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: JAGX) forecast ROA is -11.24%, which is lower than the forecast US Biotechnology industry average of 10.83%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.